Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 107, Issue 11, 2011, Pages 1597-1603

  Schoos, Mikkel Malby ^a   Kelbæk, Henning ^a   Kofoed, Klaus F ^a   Køber, Lars ^a   Kløvgaard, Lene ^a   Helqvist, Steffen ^a   Engstrøm, Thomas ^a   Saunamki, Kari ^a   Jørgensen, Erik ^a   Holmvang, Lene ^a   Clemmensen, Peter ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; ADVERSE OUTCOME; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; SURVIVAL RATE;

ANGIOPLASTY, BALLOON, CORONARY; C-REACTIVE PROTEIN; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECURRENCE;

EID: 79956071654     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.01.042     Document Type: Article

References (26)

1. M.A. Costa, and D.I. Simon Molecular basis of restenosis and drug-eluting stents Circulation 111 2005 2257 2273 (Pubitemid 40632443)
2. T. Inoue, and K. Node Molecular basis of restenosis and novel issues of drug-eluting stents Circ J 73 2009 615 621
3. F.G.P. Welt, and C. Rogers Inflammation and restenosis in the stent Era Arterioscler Thromb Vasc Biol 22 2002 1769 1776 (Pubitemid 35315761)
4. J.P. Chen, D. Hou, L. Pendyala, J.A. Goudevenos, and N.G. Kounis Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited JACC Cardiovasc Interv 2 2009 583 593
5. P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, S. Silenzi, M.L. Bacchi-Reggiani, P. Guastaroba, R. Grilli, and A. Branzi Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention Eur Heart J 29 2008 1241 1249 (Pubitemid 351768116)
6. D.W. Park, S.C. Yun, J.Y. Lee, W.J. Kim, S.J. Kang, S.W. Lee, Y.H. Kim, C.W. Lee, J.J. Kim, S.W. Park, and S.J. Park C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation Circulation 120 2009 1987 1995
7. H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Klovgaard, A. Kaltoft, B. Andersen, H. Thuesen, T. Engstrom, H.E. Botker, K. Saunamaki, L.R. Krusell, E. Jorgensen, H.H. Hansen, E.H. Christiansen, J. Ravkilde, L. Kober, K.F. Kofoed, C.J. Terkelsen, and J.F. Lassen Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial Circulation 118 2008 1155 1162
8. A. Kaltoft, H. Kelbaek, L. Thuesen, J.F. Lassen, P. Clemmensen, L. Kløvgaard, T. Engstrøm, H.E. Bøtker, K. Saunamki, L.R. Krusell, E. Jørgensen, H.H. Tilsted, E.H. Christiansen, J. Ravkilde, L. Køber, K.F. Kofoed, C.J. Terkelsen, and S. Helqvist Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) trial J Am Coll Cardiol 56 2010 641 645
9. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369 (Pubitemid 36158034)
10. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr, J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, and R.J. Glynn Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
11. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer, and E. Braunwald C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28 (Pubitemid 40075677)
12. E.Y. Yang, V. Nambi, Z. Tang, S.S. Virani, E. Boerwinkle, R.C. Hoogeveen, B.C. Astor, T.H. Mosley, J. Coresh, L. Chambless, and C.M. Ballantyne Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study J Am Coll Cardiol 54 2009 2388 2395
13. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
14. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
15. R.J. Bisoendial, J.J.P. Kastelein, J.H.M. Levels, J.J. Zwaginga, B. van den Bogaard, P.H. Reitsma, J.C.M. Meijers, D. Hartman, M. Levi, and E.S.G. Stroes Activation of inflammation and coagulation after infusion of C-reactive protein in humans Circ Res 96 2005 714 716 (Pubitemid 40559509)
16. H.D. Danenberg, A.J. Szalai, R.V. Swaminathan, L. Peng, Z. Chen, P. Seifert, W.P. Fay, D.I. Simon, and E.R. Edelman Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice Circulation 108 2003 512 515 (Pubitemid 36961161)
17. V. Pasceri, J.T. Willerson, and E.T.H. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
18. P.A. Gurbel, K.P. Bliden, R.P. Kreutz, J. Dichiara, M.J. Antonino, and U.S. Tantry The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting Platelets 20 2009 97 104
19. K. Yun, M. Jeong, S. Oh, S. Rhee, E. Park, E. Lee, N. Yoo, N.H. Kim, Y. Ahn, and J.W. Jeong Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome Heart Vessels 24 2009 175 180
20. O. Gach, V. Legrand, Y. Biessaux, J.P. Chapelle, S. Vanbelle, and L.A. Pierard Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris Am J Cardiol 99 2007 31 35 (Pubitemid 44969338)
21. A. Dibra, G. Ndrepepa, J. Mehilli, J. Dirschinger, J. Pache, H. Schhlen, A. Schmig, and A. Kastrati Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents Am J Cardiol 95 2005 1238 1240 (Pubitemid 40616430)
22. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr, J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, BrG. Nordestgaard, J. Shepherd, J.T. Willerson, and R.J. Glynn Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 2009 1175 1182
23. C.M. Colley, A. Fleck, A. Goode, B. Muller, and M. Myers Early time course of the acute phase protein response in man J Clin Pathol 36 1983 203 207 (Pubitemid 13190318)
24. I. Kushner, M. Broder, and D. Karp Control of the acute phase response Serum C-reactive protein kinetics after acute myocardial infarction J Clin Invest 61 1978 235 242 (Pubitemid 8280392)
25. A. Aggarwal, D.J. Schneider, E.F. Terrien, K.E. Gilbert, and H.L. Dauerman Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response J Thromb Thrombolysis 15 2003 25 31 (Pubitemid 37368950)
26. N. El-Mokhtari, S. Zschernitz, S. Sebens, G. Simon-Herrmann, and D. Krger Cardiac release and kinetics of cytokines after elective bare metal coronary stenting J Thromb Thrombolysis 30 2010 391 397